Ellie Simmonds is considering motherhood - but there's still room for doubt. Before making an official decision, she follows ...

Ellie Simmonds tackles motherhood and disability in a new hard-hitting documentary, as she explores the idea of becoming a ...

BioMarin sees growth from Voxzogo but faces competition and product declines. Market pressures lead to a downgrade from Buy ...

Surgery is an effective method to correct bone structure defects. Physiotherapy is helpful in increasing physical strength and making walking easier. A psychologist or counselor can help boost the ...

Team GB swimming legend Ellie Simmonds has opened up on the heartbreaking decision she faces on whether or not she should ...

The five-time Paralympic gold medallist , will look at why she might have to genetically engineer a foetus in her latest ...

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q1 CY2025 results exceeding the market’s revenue expectations, ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 ...

Meanwhile, Ascendis has a third promising drug, Transcon CNP (to treat achondroplasia), that was submitted for FDA approval in Q1 and could be launched in 2026.” Ascendis Pharma A/S (NASDAQ ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth hormone deficiency (GHD) programs during ESPE & ESE 2025, the ...

COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth ...